Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesC3-K2-E14 is an ionizable cationic lipid.1,2 It has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA, siRNA, and long intergenic noncoding RNA (lncRNA) in vitro and in vivo. LNPs containing C3-K2-E14 and encapsulating siRNA targeting the gene encoding colony-stimulating factor 1 (CSF1) reduce the percentage of circulating monocytes with high expression of lymphocyte antigen 6 complex, locus protein C (Ly6Chi) and increase the percentage of circulating monocytes with intermediate Ly6C expression (Ly6Cint) in mice.1 LNPs containing C3-K2-E14 and encapsulating gastric adenocarcinoma predictive long intergenic noncoding RNA (GAPLINC) reduce LPS-induced NF-κB activation in a secreted alkaline phosphatase (SEAP) assay using RAW 264.7 reporter cells.2
WARNING This product is not for human or veterinary use.
1. Ionizable lipid with supramolecular chemistry features for RNA delivery in vivo. Small 19(41), e2302917 (2023).
2. Human and mouse long noncoding RNAs reengineered for exogenous delivery reduce LPS-